
Join to View Full Profile
300 Pasteur DrPalo Alto, CA 94304
Phone+1 650-723-4000
Dr. DeJong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California San Francisco School of MedicineClass of 2016
Certifications & Licensure
- CA State Medical License 2019 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Heart Failure Polypill at a Safety Net Hospital Start of enrollment: 2024 Feb 27
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsPrototyping and Manufacturing of Customized Over-Encapsulated Polypills for Heart Failure With Reduced Ejection Fraction in a Safety-Net Health Care System.Colette Dejong, Matthew S Durstenfeld, Jonathan D Davis, Christina S Wang, Justin C Chen
Journal of Cardiac Failure. 2025-03-30 - Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-H...Colette DeJong, Matthew S Durstenfeld, Jonathan D Davis, Christina S Wang, Elise D Riley
BMJ Open. 2025-03-21 - Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction.Colette DeJong, Kosuke Inoue, Matthew S Durstenfeld, Anubha Agarwal, Justin C Chen
JACC. Heart Failure. 2025-03-12
Journal Articles
- Deferral of Care for Serious Non–COVID-19 ConditionsColette Dejong, Kenneth Covinsky, JAMA Internal Medicine
- Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part DColette Dejong, Chien-Wen Tseng, JAMA Internal Medicine
- Multivessel or Culprit Vessel–Only Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction and Cardiogenic ShockColette Dejong, Rita F Redberg, JAMA Internal Medicine
- Join now to see all
Authored Content
- An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the USMay 2020
- An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the USMay 2020
Press Mentions
- Direct Marketing to Cardiologists Increases Uptake of Some, but Not All, Heart Failure DrugsMarch 21st, 2025
- Hospital Volumes Declined Amid Springtime COVID PandemicOctober 28th, 2020
- Deferral of Care for Serious Non–COVID-19 ConditionsOctober 26th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: